Saturday, December 14, 2019

 


Acasti Pharma Inc
(TSX-V: ACST.VN) Add to Watchlist
$2.680
+0.370 (+16.02%)
as of Dec 13, 2019

Last 2.680
Change +0.370 (+16.02%)
Open 2.320
Prev. Close 2.310
Today's Range
2.310 2.710
52wk Range
0.890 3.880
Volume 277,893
Avg Volume 145,036

Recent Headlines
Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ: ACST - TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia (triglyceride blood l  (full story)
ACST: 2.04 (+0.29), ACST.VN: 2.680 (+0.370)
A lot of cancer research is dealing with shrinking brain tumors and opening the door for targeted cancer therapies to work without damaging the surrounding tissue. The success rate for cancer therapies has been limited due to a combination of factors, such as the tumor's ability to hide from and dev  (full story)
CNSP: 3.95 (-0.08), AMRN: 24.12 (+1.13), TEVA: 9.64 (-0.16), KRTX: 65.25 (-8.26), ACST: 2.04 (+0.29), ACST.VN: 2.680 (+0.370)
-- Preliminary, statistically significant findings show that CaPre may promote insulin secretion, and showed a significant increase in plasma levels of 17S-HDHA and PDX as compared to metformin and icosapent ethyl  (full story)
ACST: 2.04 (+0.29), ACST.VN: 2.680 (+0.370)
For decades researchers have been trying to find newer and more effective ways to fight cancer cells. Today much research is focused on attacking the cancerous cells growth. The reasoning is that denying these cells energy, they will die. The idea is that by using targeted therapies only the cancero  (full story)
MBRX: 1.02 (+0.01), AMRN: 24.12 (+1.13), KDMN: 4.73 (-0.01), PFE: 38.33 (-0.21), ACST: 2.04 (+0.29), ACST.VN: 2.680 (+0.370)
Acasti Pharma Inc. ("Acasti or the "Company") (NASDAQ: ACST - TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre(R) (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia (triglyceride blood  (full story)
ACST: 2.04 (+0.29), ACST.VN: 2.680 (+0.370)
Performance Comparison
Name Today 3-Month 1-Year
ACST.VN +16.02% +7.20% +201.12%
$TXCX +0.33% +3.87% +15.27%
$TXCI +0.25% +3.82% +14.56%
DJIA +0.01% +7.38% +14.38%
S&P 500 +0.01% +8.87% +19.55%

Key Statistics
Annual EPS -0.570
Dividend & Yield -- (--)
P/E Ratio N/A
Market Capitalization, $K 197,102
Weighted Alpha +117.80
Standard Deviation +3.17
Profit Margin --
Beta -0.364

Growth Rates
YTD +135.09%
1-Year +194.51%
3-Year +76.32%
© 2019 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.